What will the cannabis industry look like in 1-2 years? In this interview with Shadd Dales of @TheDalesReport, InMed CEO, Eric A. Adams, talks about how modern cannabinoid manufacturing techniques will change the industry.
What quality controls should be put in place to ensure consistency and purity of cannabinoids for CPG products?
Dr. Shane Johnson, GM of BayMedica, InMed’s subsidiary, answers these questions: What is the minimum GMP standard that consumers should expect? What quality controls should